Table 1.
Descriptions of different inflammatory markers used for the study or diagnosis of AD
Marker | Species in which it exists related with AD studies | Potential use in clinical diagnosis | Function in inflammation | References |
---|---|---|---|---|
TLR2 | Human, mouse, rat |
- Non-alcoholic fatty liver disease (NAFLD) - Non-alcoholic steatohepatitis (NASH) - Chronic lymphocytic leukemia - Acute coronary syndrome |
Receptor which interacts with Aβ | [52, 194–199] |
MHCII | Human, mouse, rat |
- Triple-negative breast cancer (TNBC) - Systemic lupus erythematosus - Ovarian cancer |
Antigen presenter | [200–205] |
Iba-1 | Human, mouse, rat |
- Traumatic brain injury - Frontotemporal lobar degeneration - Epilepsy - Postoperative cognitive decline |
Intracellular protein of microglia, related to support the phagocytosis process |
[206–212] |
GFAP | Human, mouse, rat |
- GFAP autoimmunity - Traumatic brain injury - Alexander disease - Multiple sclerosis |
Mediates astroglia cell activation | [213–220] |
TNF-α | Human, mouse, rat |
- Psoriasis - Rheumatoid arthritis - Alzheimer’s disease - Type 2 diabetes mellitus |
Pro-inflammatory cytokine | [24, 128, 131, 137, 221–225] |
IL-1 | Human, mouse, rat |
- Systemic juvenile idiopathic arthritis - Rheumatoid arthritis - Gout - Familial Mediterranean fever -Muckle-Wells syndrome - Acute myocardial infarction - Heart failure - Type 2 diabetes |
Pro-inflammatory cytokine | [24, 225–230] |
NF- κB | Human, mouse, rat |
- Preeclampsia - Degenerative Disc Disease - Colorectal cancer - Non-medullary thyroid cancer |
Transcription factor that activates genes related to inflammation | [133, 231–237] |